These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17183669)

  • 1. Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology.
    Forgber M; Basu R; Roychoudhury K; Theinert S; Roy S; Sundar S; Walden P
    PLoS One; 2006 Dec; 1(1):e40. PubMed ID: 17183669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 12.6-kDa protein of Leishmania donovani for the diagnosis of Indian visceral leishmaniasis.
    Kumar D; Kumar S; Chakravarty J; Sundar S
    Vector Borne Zoonotic Dis; 2011 Oct; 11(10):1359-64. PubMed ID: 21923256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages.
    Basu R; Roy S; Walden P
    J Infect Dis; 2007 May; 195(9):1373-80. PubMed ID: 17397010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
    Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
    Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines.
    Arora SK; Pal NS; Mujtaba S
    Exp Parasitol; 2005 Mar; 109(3):163-70. PubMed ID: 15713447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host humoral immune response to Leishmania lipid-binding protein.
    Maache M; Azzouz S; Diaz de la Guardia R; Alvarez P; Gil R; de Pablos LM; Osuna A
    Parasite Immunol; 2005 Jun; 27(6):227-34. PubMed ID: 16048642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani.
    Sivakumar R; Sharma P; Chang KP; Singh S
    Protein Expr Purif; 2006 Mar; 46(1):156-65. PubMed ID: 16172002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of a Novel, 37-Kilodalton Leishmania donovani antigen for diagnosis of Indian visceral leishmaniasis.
    Kumar S; Kumar D; Chakravarty J; Sundar S
    Clin Vaccine Immunol; 2011 May; 18(5):772-5. PubMed ID: 21411602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Leishmania chagasi by 2-D difference gel electrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine.
    Costa MM; Andrade HM; Bartholomeu DC; Freitas LM; Pires SF; Chapeaurouge AD; Perales J; Ferreira AT; Giusta MS; Melo MN; Gazzinelli RT
    J Proteome Res; 2011 May; 10(5):2172-84. PubMed ID: 21355625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antibody responses in Indian kala-azar by immunoblot.
    Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
    Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL; Rachamim N; Sarfstein R
    J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India.
    Singh N; Sundar S
    Exp Parasitol; 2017 May; 176():30-45. PubMed ID: 28263760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
    Salotra P; Raina A; Negi NS
    Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
    Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.